Strategic process -- Formal engagement with Evercore concluded; current focus is on Phase III clinical execution, with ...

UPPSALA, SE / ACCESS Newswire / November 11, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF), a leader in solutions for personalized anesthesia, today announced that Philip Siberg, CEO of Senzime, will be pres ...

Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy for advanced and metastatic Merkel cell ...

On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q3 2025 Earnings Call Transcript November 12, 2025 Atea Pharmaceuticals, Inc.

Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsJonae Barnes - Senior Vice President of ...

Researchers have designed a smart drug that hunts down and breaks a little-known RNA that cancer cells depend on. The drug ...

A remote-controlled robot the size of a grain of sand can swim through blood vessels to deliver drugs before dissolving into ...

FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study EB613 Phase 2 Data Demonstrating Consistent ...

There is basically no research that looks at the impact of antidepressants on emerging sexuality. Here are the key things we ...

Initiated registrational Phase 2b SAFEGUARD trial of SAB-142 in new-onset, Stage 3 autoimmune T1D patientsMultiple SAFEGUARD ...

India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease ...